European Pharmaceutical Review

SEPTEMBER 22, 2023

Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5

Food and Drug Administration 97

Food and Drug Administration Safety Patients Leads 97

Pharmaceutical Technology

JULY 23, 2008

The world’s biggest pharmaceutical company Pfizer announced in June 2008 that it would be putting its “full scope and scale” behind a push into the cancer market. ” “Between 2003 and 2005 global sales for cancer-treating drugs grew by 40%.”

Side effects 40

Side effects Marketing Pharmaceutical Sales 40

Pharma Marketing Network

JANUARY 26, 2022

Throughout her decades-long career, Seidenberg has transformed the lives of millions of patients by championing pharmaceutical research and development leading to the introduction of innovative life-saving products that treat diseases like AIDS, arthritis, asthma, cancer, and others.

Healthcare 40

Healthcare Healthcare Networking Recruitment 40